Search results
Investors Title (NASDAQ:ITIC) Shares Pass Above 200-Day Moving Average of $160.97
ETF DAILY NEWS· 7 hours agoInvestors Title (NASDAQ:ITIC – Get Free Report) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $160.97 and traded as high ...
Q32 Bio (NASDAQ:QTTB) Receives New Coverage from Analysts at Guggenheim
ETF DAILY NEWS· 7 hours agoGuggenheim assumed coverage on shares of Q32 Bio (NASDAQ:QTTB – Free Report) in a research report released on Monday, Marketbeat reports. The firm issued a buy rating and a $100.00 target price ...
Oppenheimer Lowers Cellectis (NASDAQ:CLLS) Price Target to $10.00
ETF DAILY NEWS· 4 days agoCellectis (NASDAQ:CLLS – Get Free Report) had its target price dropped by Oppenheimer from $11.00 to $10.00 in a note issued to investors on Wednesday, Benzinga reports. The ...
Cartesian Therapeutics (NASDAQ:RNAC) Given Buy Rating at HC Wainwright
ETF DAILY NEWS· 7 hours agoHC Wainwright reiterated their buy rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a report published on Monday morning, Benzinga reports. They currently have a $54.00 ...
Cartesian Therapeutics (NASDAQ:RNAC) Receives “Outperform” Rating from Oppenheimer
ETF DAILY NEWS· 3 days agoOppenheimer restated their outperform rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a report issued on Friday, Benzinga reports. They currently ...
Alexis Ren Asks for an Open Mind as She Takes On Her Biggest Movie Role with ‘Latency’
The Hollywood Reporter· 15 hours agoLatency star Alexis Ren knows full well the perception that comes with a social media star making...
89bio, Inc. (NASDAQ:ETNB) Receives $28.14 Consensus Price Target from Analysts
ETF DAILY NEWS· 7 hours ago89bio, Inc. (NASDAQ:ETNB – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven analysts that are presently covering the stock, Marketbeat.com reports. Two equities ...
Cytokinetics, Incorporated (NASDAQ:CYTK) Director B Lynne Parshall Sells 5,000 Shares
ETF DAILY NEWS· 4 hours agoCytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director B Lynne Parshall sold 5,000 shares of the business’s stock in a transaction on Monday, June 17th. Following the completion ...
Oppenheimer Increases Moderna (NASDAQ:MRNA) Price Target to $179.00
ETF DAILY NEWS· 4 days agoModerna (NASDAQ:MRNA – Get Free Report) had its target price hoisted by analysts at Oppenheimer from $163.00 to $179.00 in a research report issued to clients and investors ...
A Pill Hill home alive with history is connected to 'Oppenheimer'
Post-Bulletin, Rochester, Minn. via Yahoo News· 4 days agoJun. 14—ROCHESTER — On the historic streets of Pill Hill, the homes share preservation and elegance. There's even a stucco exterior home that Luis Alvarez, a Manhattan Project contributor depicted ...